Form 4: Avidity Biosciences Chief Medical Officer Sells Shares to Cover Tax Obligations

Avidity Biosciences' Chief Medical Officer, Steven George Hughes, sold shares to cover tax obligations related to vesting of Restricted Stock Units (RSUs).

Summary

• Steven George Hughes, Chief Medical Officer of Avidity Biosciences, sold a total of 3,947 shares of common stock on January 21, 2025.
• The sales were executed to cover tax withholding obligations associated with the vesting of RSUs on January 20, 2025.
• The shares were sold in multiple transactions at weighted average prices of $28.5955 and $28.5906.
• The sales were not discretionary trades but were mandated by the company's equity incentive plan.
• The reporting person has an instruction letter for automatic sales of 'sell-to-cover' shares under Rule 10b5-1.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, not indicative of any positive or negative sentiment towards the company's performance.

Industry Context

This is a routine transaction for executives who receive equity compensation. It is common for companies to have 'sell-to-cover' arrangements to manage tax obligations.

Comparison to Industry Standards

• Many biotechnology companies use equity compensation as part of their overall compensation strategy.
• Sell-to-cover transactions are a standard practice to manage tax liabilities associated with vesting equity.
• The price range of the sales is within the expected range for a company of this type.

Stakeholder Impact

• The share sales have a minimal impact on shareholders as they are part of a routine tax obligation process.

Key Dates

Keywords

Avidity Biosciences, share sale, insider trading, Form 4, Chief Medical Officer, tax obligations, RSUs, equity incentive plan, Rule 10b5-1, sell-to-cover